Through transcriptome-based immunogram analysis, immunological microenvironment including Wnt/β-catenin activation, high combined positive score of PD-L1, and increased infiltration of CD8+ cells in HCC were found significantly associated with longer survival in HCC patients receiving ICI treatments [25]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.